Can Fite Biofarma (AMEX:CANF) reported its Q1 earnings results on Thursday, May 26, 2022.
Here’s what investors need to know about the announcement.
Earnings
Can Fite Biofarma missed estimated earnings by 100.0%, reporting an EPS of $0.0 versus an estimate of $-0.14.
Revenue was up $57.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.17 which was followed by a 4.35% increase in the share price the next day.
Here’s a look at Can Fite Biofarma’s past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.18 | -0.09 | -0.10 | -0.16 |
| EPS Actual | -0.01 | -0.20 | -0.01 | 0 |
| Revenue Estimate | 250.00K | 150.00K | 120.00K | 200.00K |
| Revenue Actual | 204.00K | 251.00K | 250.00K | 148.00K |
To track all earnings releases for Can Fite Biofarma visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.